Taysha Gene Therapies has announced an important milestone for the Queen’s University clinical trial for TSHA-118, a CLN1 disease clinical trial funded by Taysha Gene Therapies. Please read the community letter here – Batten Disease Support & Research Association

Taysha Gene Therapies has announced an important milestone for the Queen’s University clinical trial for TSHA-118, a CLN1 disease clinical trial funded by Taysha Gene Therapies. Please read the community letter here

Please read the community letter here:

A Letter to the CLN1 Community from Taysha

By Morgan Deboth|2021-12-16T18:10:49-05:00December 16th, 2021|Latest News|Comments Off